Keyword: Foundation Medicine
The alliance will see Foundation Medicine use pan-cancer test FoundationOne CDx as a companion diagnostic for Pfizer drugs.
The past week's research news included developments in pediatric brain tumors, asthma and KRAS-mutant cancers.
Guardant Health filed suit against Foundation Medicine in a U.S. District Court in California for false advertising and unfair competition.
Gritstone Oncology has appointed Raphaël Rousseau, M.D., Ph.D., as its CMO.
Eisai’s spinoff unit H3 Biomedicine has expanded its 2015 deal with Foundation Medicine as the pair look for new cancer drivers.